Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Long-Term Data Confirm the Superiority of Total Body Irradiation-Containing Conditioning Regimen in Comparison to a Chemotherapy-Based Preparation in Children with Acute Lymphoblastic Leukemia Above the Age of 4 Years Given an Unmanipulated Allograft. Results of the Forum Randomized Clinical Trial

Franco Locatelli, Peter Bader, Jean-Hugues Dalle, Ulrike Poetschger, Herbert Pichler, Petr Sedlacek, Jochen Büchner, Peter J. Shaw, Marianne Ifversen, Raquel Staciuk, Kim Vettenranta, Adriana Balduzzi, Christina Peters

Blood (2022) 140 (Supplement 1): 4865–4867.

https://doi.org/10.1182/blood-2022-166048

Published: 2022

Journal Articles

Relapse risk following truncation of pegylated asparaginase in childhood acute lymphoblastic leukemia

Sofie Gottschalk Højfeldt, Kathrine Grell, Jonas Abrahamsson, Bendik Lund, Kim Vettenranta, Ólafur G. Jónsson, Thomas L. Frandsen, Benjamin O. Wolthers, Hanne Vibeke Marquart, Goda Vaitkeviciene, Kristi Lepik, Mats Heyman, Kjeld Schmiegelow, Birgitte Klug Albertsen

Blood (2021) 137 (17): 2373–2382.

https://doi.org/10.1182/blood.2020006583

Published: 2021

Includes: Supplemental data

Journal Articles

RhoG deficiency abrogates cytotoxicity of human lymphocytes and causes hemophagocytic lymphohistiocytosis

Blood (2021) 137 (15): 2033–2045.

https://doi.org/10.1182/blood.2020008738

Published: 2021

Includes: Supplemental data

Journal Articles

Intensive Chemotherapy for High-Risk ALL in Children - the Nordic Collaborative Approach

Atte Nikkilä, MD, Olli Lohi, MD PhD, Ólafur Gísli Jónsson, MD PhD, Bendik Lund, MD PhD, Jonas Abrahamsson, Goda Elizabeta Vaitkeviciene, MD PhD, Kaie Pruunsild, MD, Mats Heyman, MD PhD, Hanne Vibeke Marquart, MD PhD, Kim Vettenranta, MD PhD, Kjeld Schmiegelow, MD PhD

Blood (2019) 134 (Supplement_1): 742.

https://doi.org/10.1182/blood-2019-122914

Published: 2019

Journal Articles

Value of Flow Cytometry for MRD-Based Relapse Prediction in B-Cell Precursor Acute Lymphoblastic Leukemia in a Multi-Center Setting

Blood (2019) 134 (Supplement_1): 2755.

https://doi.org/10.1182/blood-2019-122311

Published: 2019

Journal Articles

Intermittent Vs Continuous Asparaginase to Reduce Asparaginase-Associated Toxicities: A NOPHO ALL2008 Randomized Study

Birgitte Klug Albertsen, MD, Jonas Abrahamsson, MD PhD, Bendik Lund, MD PhD, Kim Vettenranta, MD PD, Ólafur G. Jónsson, MD, Thomas Leth Frandsen, MD PhD, Benjamin Ole Wolthers, MD, Kathrine Grell, PhD, Mats Heyman, MD PhD, Kjeld Schmiegelow, MD

Blood (2017) 130 (Supplement 1): 1275.

https://doi.org/10.1182/blood.V130.Suppl_1.1275.1275

Published: 2017

Journal Articles

Stem Cell Transplantation for Congenital Dyserythropoietic Anemia. a Retrospective Study on Behalf of Severe Aplastic Anemia Working Party of the European Blood and Marrow Transplantation Group (EBMT)

Blood (2017) 130 (Supplement 1): 4600.

https://doi.org/10.1182/blood.V130.Suppl_1.4600.4600

Published: 2017

Journal Articles

Individualized 6-Mercaptopurine Increments in Consolidation Treatment of Childhood Acute Lymphoblastic Leukemia: A NOPHO ALL2008 Randomized Controlled Trial

Morten Tulstrup, MD, Thomas Leth Frandsen, MD PhD, Jonas Abrahamsson, MD PhD, Bendik Lund, MD PhD, Kim Vettenranta, MD PhD, Olafur G. Jonsson, MD PhD, Hanne Vibeke Marquart, MD PhD, Birgitte Klug Albertsen, MD, Mats Heyman, MD PhD, Kjeld Schmiegelow, MD

Blood (2017) 130 (Supplement 1): 142.

https://doi.org/10.1182/blood.V130.Suppl_1.142.142

Published: 2017

Journal Articles

Wiskott-Aldrich Syndrome: A Retrospective Study on 575 Patients Analyzing the Impact of Splenectomy, Stem Cell Transplantation, or No Definitive Treatment on Frequency of Disease-Related Complications and Physician-Perceived Quality of Life

Jannik S Glasmacher, Tanja C Bittner, MD, Hans D Ochs, MD, Alessandro Aiuti, MD PhD, Peter D Arkwright, MD, Dmitry Balashov, Uta Behrends, Bernd H. Belohradsky, MD, Elisa Bertoni, David K. Buchbinder, MD MSHS, Michael Browning, Anastasiia Bondarenko, Fabio Candotti, MD, Alessandro Cattoni, Liudmyla Chernyshova, Joseph H. Chewning, MD, Peter Ciznar, Theresa Cole, Beatriz T Costa-Carvalho, Wojciech Czogala, Gregor Dueckers, David M Edgar, Fatih Erbey, Anders Fasth, MD PhD, Renata Formankova, MD PhD, Tomas Freiberger, Eleonora Gambineri, Andrew Gennery, MD, Frederick D Goldman, MD, Luis I Gonzalez-Granado, Tiago N Gulmaraes, David Hagin, MD PhD, Fabian Hauck, MD PhD, Tarja Heiskanen-Kosma, Manfred Hoenig, MD, Hanna Juntti, Hirokazu Kanegane, Leena Kainulainen, Neslihan E Karaca, Sara S Kilic, Christoph Klein, MD PhD, Sylwia Koltan, Irina Kondratenko, Dawei Liu, MD, Susanne Matthes, MD, Juliana T L Mazzucchelli, Isabelle Meyts, Siraj Misbah, Zohreh Nademi, Gulnara Nasrullayeva, Lucia D Notarangelo, Pere Soler-Palacin, Olga Pashchenko, Srdjan Pasic, Isabelle Pellier, MD, Claudio Pignata, Camilla Roepstorff, Catharina Schuetz, Ansgar S Schulz, MD PhD Prof., Gesmar R S Segundo, Anna Shcherbina, Joanne Smart, Robert A. Sokolic, MD, Polina Stepensky, MD, Troy Torgerson, MD PhD, Svetlana Vakhlyarskaya, Joris van Montfrans, MD PhD, Kim Vettenranta, MD PD, Beata Wolska-Kusnierz, Xiaodong Zhao, John B Ziegler, Xuan Zhang, Michael H. Albert, MD

Blood (2016) 128 (22): 366.

https://doi.org/10.1182/blood.V128.22.366.366

Published: 2016

Journal Articles

Outcomes of Cord Blood Transplantation from an HLA-Identical Sibling for Patients with Inherited or Acquired Bone Marrow Failure Disorders: A Report from Eurocord, Cord Blood Committee (CBC-CTIWP) and Severe Aplastic Anemia Working Party (SAAWP) of the European Group of Blood and Bone Marrow Transplantation (EBMT)

Simona Pagliuca, Régis Peffault de Latour, MD, Franco Locatelli, Prof, MD PhD, Jean-Hugues Dalle, PhD MD, Kim Vettenranta, MD PD, Miguel Angel Diaz, MD PhD, Or Reuven, Cristina Diaz de Heredia, MD, Arnon Nagler, MD MSc, Ardeshir Ghavamzadeh, Professor, Sabina Sufliarska, MD, Sarah Lawson, Chantal Kenzey, CRA, Vanderson Rocha, MD PhD, Carlo Dufour, MD, Eliane Gluckman, MD, Jakob Passweg, Annalisa Ruggeri, MD PhD

Blood (2015) 126 (23): 153.

https://doi.org/10.1182/blood.V126.23.153.153

Published: 2015

Journal Articles

Germline Mutations within the IL2-Inducible T Cell Kinase Impede T Cell Differentiation or Survival, Cause Protein Destabilisation, Loss of Membrane Recruitment and Lead to Severe EBV Lymphoproliferation

Rene Martin Linka, Kirsten Huck, Frank Krux, Polina Stepenski, Cindy Synaeve, Kim Vettenranta, MD, PhD, Rene Deenen, Ingrid Müller-Fleckenstein, Yvonne Linka, Sebastian Ginzel, Anne Halenius, Karl Köhrer, Bernhard Fleckenstein, Hans Jürgen Laws, Roland Hartig, Burkhart Schraven, Sylvain Latour, Arndt Borkhardt, MD

Blood (2010) 116 (21): 280.

https://doi.org/10.1182/blood.V116.21.280.280

Published: 2010

Journal Articles

Methotrexate/6-mercaptopurine maintenance therapy influences the risk of a second malignant neoplasm after childhood acute lymphoblastic leukemia: results from the NOPHO ALL-92 study

Kjeld Schmiegelow, Ibrahim Al-Modhwahi, Mette Klarskov Andersen, Mikael Behrendtz, Erik Forestier, Henrik Hasle, Mats Heyman, Jon Kristinsson, Jacob Nersting, Randi Nygaard, Anne Louise Svendsen, Kim Vettenranta, Richard Weinshilboum

Blood (2009) 113 (24): 6077–6084.

https://doi.org/10.1182/blood-2008-11-187880

Published: 2009

Journal Articles

Response: Could mutations in the hypoxanthine-guanine phosphoribosyl transferase gene induced by thiopurine therapy promote the development of second malignant neoplasms?

Kjeld Schmiegelow, Ibrahim Al-Modhawi, Mette Klarskov Andersen, Mikael Berendtz, Erik Forestier, Henrik Hasle, Mats Heyman, Jon Kristinsson, Jacob Nersting, Randi Nygaard, Anne Louise Svendsen, Kim Vettenranta, Richard Weinshilboum

Blood (2009) 113 (24): 6258–6259.

https://doi.org/10.1182/blood-2009-03-210195

Published: 2009

Journal Articles

Clinical Outcome of 640 Children with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Treated Between 1995 and 2005

Maurizio AricÃ², MD, Martin Schrappe, MD, Stephen Hunger, MD, William L. Carroll, MD, Valentino Conter, MD, Paola Di Lorenzo, Atsushi Manabe, MD, PhD, Vaskar Saha, Andre Baruchel, MD, Kim Vettenranta, MD, PD, Masahiro Tsuchida, Yves Benoit, Rob Pieters, MD, PhD, Gabriele Escherich, Lewis B. Silverman, MD, Ching-Hon Pui, MD, Maria Grazia Valsecchi

Blood (2008) 112 (11): 568.

https://doi.org/10.1182/blood.V112.11.568.568

Published: 2008

Journal Articles

Acute Lymphoblastic Leukemia with “Normal” Karyotype is not without Genomic Aberrations.

Anu Usvasalo, Riikka Räty, Arja Harila-Saari, Pirjo Koistinen, Eeva-Riitta Savolainen, Kim Vettenranta, Sakari Knuutila, Erkki Elonen, Ulla M. Saarinen-Pihkala

Blood (2008) 112 (11): 1491.

https://doi.org/10.1182/blood.V112.11.1491.1491

Published: 2008

Journal Articles

Acute Lymphoblastic Leukemia in Adolescents and Young Adults in Finland.

Anu Usvasalo, Ulla Saarinen-Pihkala, Erkki Elonen, Riikka Raty, Kim Vettenranta

Blood (2006) 108 (11): 1885.

https://doi.org/10.1182/blood.V108.11.1885.1885

Published: 2006

Journal Articles

Risk of Second Malignant Neoplasm Is Related to TPMT Activity and Duration of MTX/6MP Maintenance Therapy of ALL.

Kjeld Schmiegelow, MD, Ibrahim Al-Modhawi, M.D., Mikael Berendtz, M.D., Erik Forestier, M.D., Henrik Hasle, M.D., Mats Heyman, M.D., Jon Kristinsson, M.D., Randi Nygaard, M.D., Kim Vettenranta, M.D.

Blood (2006) 108 (11): 1853.

https://doi.org/10.1182/blood.V108.11.1853.1853

Published: 2006

Journal Articles

Thymic Recovery among Pediatric Stem Cell Recipients.

Helena Olkinuora, MD, Tanja Kaartinen, S.ch, Sanna Siitonen, MD, Kimmo Talvensaari, MD, Ulla Pihkala, MD, Kim Vettenranta, MD

Blood (2005) 106 (11): 1422.

https://doi.org/10.1182/blood.V106.11.1422.1422

Published: 2005

NARROW

Long-Term Data Confirm the Superiority of Total Body Irradiation-Containing Conditioning Regimen in Comparison to a Chemotherapy-Based Preparation in Children with Acute Lymphoblastic Leukemia Above the Age of 4 Years Given an Unmanipulated Allograft. Results of the Forum Randomized Clinical Trial

Relapse risk following truncation of pegylated asparaginase in childhood acute lymphoblastic leukemia

RhoG deficiency abrogates cytotoxicity of human lymphocytes and causes hemophagocytic lymphohistiocytosis

Intensive Chemotherapy for High-Risk ALL in Children - the Nordic Collaborative Approach

Value of Flow Cytometry for MRD-Based Relapse Prediction in B-Cell Precursor Acute Lymphoblastic Leukemia in a Multi-Center Setting

Intermittent Vs Continuous Asparaginase to Reduce Asparaginase-Associated Toxicities: A NOPHO ALL2008 Randomized Study

Stem Cell Transplantation for Congenital Dyserythropoietic Anemia. a Retrospective Study on Behalf of Severe Aplastic Anemia Working Party of the European Blood and Marrow Transplantation Group (EBMT)

Individualized 6-Mercaptopurine Increments in Consolidation Treatment of Childhood Acute Lymphoblastic Leukemia: A NOPHO ALL2008 Randomized Controlled Trial

Wiskott-Aldrich Syndrome: A Retrospective Study on 575 Patients Analyzing the Impact of Splenectomy, Stem Cell Transplantation, or No Definitive Treatment on Frequency of Disease-Related Complications and Physician-Perceived Quality of Life

Germline Mutations within the IL2-Inducible T Cell Kinase Impede T Cell Differentiation or Survival, Cause Protein Destabilisation, Loss of Membrane Recruitment and Lead to Severe EBV Lymphoproliferation

Methotrexate/6-mercaptopurine maintenance therapy influences the risk of a second malignant neoplasm after childhood acute lymphoblastic leukemia: results from the NOPHO ALL-92 study

Response: Could mutations in the hypoxanthine-guanine phosphoribosyl transferase gene induced by thiopurine therapy promote the development of second malignant neoplasms?

Clinical Outcome of 640 Children with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Treated Between 1995 and 2005

Acute Lymphoblastic Leukemia with “Normal” Karyotype is not without Genomic Aberrations.

Acute Lymphoblastic Leukemia in Adolescents and Young Adults in Finland.

Risk of Second Malignant Neoplasm Is Related to TPMT Activity and Duration of MTX/6MP Maintenance Therapy of ALL.

Thymic Recovery among Pediatric Stem Cell Recipients.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only